Use of fused imidazole derivatives to mediate CCR3 related conditions

Details for Australian Patent Application No. 2006286699 (hide)

Owner Novartis AG

Inventors Beckwith, Rohan; Hoegenauer, Kate; Jenkins, Jeremy Lee; Ullrich, Thomas; Weigand, Klaus; Lehr, Philipp

Agent Davies Collison Cave

Pub. Number AU-A-2006286699

PCT Pub. Number WO2007/025751

Priority 0517966.8 02.09.05 GB

Filing date 31 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/025751 Priority application(s): WO2007/025751

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286703-Emulsions for confectionery applications

2006286683-Method and device for increasing the operational flexibility of a currentgenerating system, in particular a gas turbine or steam turbine